ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

July 26, 1991

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

Gerstner Resigns From NA, MSK Board After Taking RJR Job

March 24, 1989